Xsolla Joins GameDev.World 2023 as Diamond Sponsor Fostering Global Game Development Unity & Equality
Xsolla, a global video game commerce company, is excited to announce its platinum sponsorship of GameDev.World, a pioneering global real-time conference for video game developers. The event, hosted online from December 9, 2023, 11 am UK time, to December 10, 2023, 2 am UK time, is uniquely programmed in GMT to cater to an international audience.
"Joining GameDev.World as the Diamond Sponsor is a step forward in our mission to democratize game development globally," expressed Chris Hewish, CEO of Xsolla. "Our involvement in this event signifies our unwavering commitment to the gaming community and our ambition to bridge the gap for underrepresented territories in the gaming industry."
A highlight of GameDev.World is its diverse roster of speakers. Among them is Nathan Sölbrandt, who will present a pre-recorded session from 6:45 pm to 7:10 pm UK time. His segment promises to offer valuable insights into the evolving world of game development. Following him is Alessandro Biollo Menjivar, scheduled to speak live on the Spanish track from 7:55 pm to 8:20 pm UK time. Alessandro's session is anticipated to bring a unique perspective, further enriching the conference's diverse program.
The event's commitment to inclusivity and global outreach is underlined by the provision of content in eight languages: English, Arabic, Hindi, Chinese, Portuguese-Brazilian, French, Spanish, and Japanese. This aligns seamlessly with Xsolla's vision of creating a more accessible and connected gaming world. In addition to the speaker sessions, attendees can obtain a comprehensive one-page information sheet on the Funding team, available in all eight languages.
Attendees are also invited to book a meeting with Xsolla experts at GameDev.World. This presents an opportunity to discover how Xsolla's comprehensive tools and services are specifically designed to support the gaming industry. For booking a meeting and more detailed information about the conference, please visit: https://xsolla.events/gamedev-world-2023
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, and cities around the world, Xsolla supports major gaming titles like Valve, Twitch, Roblox, Epic Games, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, and more.
For additional information and to learn more, please visit: xsolla.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Director of Public Relations, Xsolla
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair26.2.2024 17:19:00 EET | Press release
Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today that preeminent ophthalmologist Eric D. Donnenfeld, MD will Chair its U.S. Medical Advisory Board (MAB) which includes Richard Lindstrom, MD (Minnesota), Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, OD (Kentucky), Lisa Nijm, MD, JD (Illinois), and Selina McGee, OD (Oklahoma). Dr. Donnenfeld joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® canalicular gel. The FDA-cleared hyaluronic acid derivative LACRIFILL is intended to temporarily block tear drainage by the occlusion of the canalicular system. “Nordic Pharma continues to build a world class group of key opinion leaders with Eric agreeing to lead our esteemed MAB in the U.S. as we prepare to bring LACRIFILL to market. With over 30 years of clinical experience as an internationally recognized expert and pioneer in refractive, cornea and catarac
Adtran recognized among STL Partners’ top 100 edge computing companies for 202426.2.2024 16:00:00 EET | Press release
Adtran today announced that it has been recognized as one of STL Partners’ top 100 edge computing companies for 2024, marking its second consecutive year of inclusion on the list. The acknowledgment reaffirms Adtran’s substantial contributions to the sector and highlights its role as a leader, driving innovation amidst the quickly evolving edge computing landscape. This leadership is increasingly vital as more enterprises and service providers seek options beyond centrally deployed, hyperscale clouds to support their business requirements of reducing hosting and backhaul costs, improving service performance and security, and accelerating time to market. This is especially true for the next wave of AI and IoT applications being deployed in various industries, such as manufacturing, transportation, logistics, healthcare, finance, media, retail and the public sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226247955/e
Vantage Data Centers Names Two New Regional Presidents to Support Market Growth Amidst Booming Cloud and AI Demand26.2.2024 16:00:00 EET | Press release
Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced the appointments of Dana Adams and David Howson who will serve as regional presidents of North America and EMEA, respectively. The company also announced that Antoine Boniface, who has served as president of EMEA for the past four years, will take on a new role as chief commercial officer for the region. These appointments come as the company enters 2024 positioned for another year of significant growth and expansion across the globe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226667521/en/ Dana Adams has joined Vantage Data Centers as President, North America. (Photo: Business Wire) Adams joins Vantage’s executive leadership team as president of North America, bringing nearly 18 years of experience in the data center sector to the company. Based in Denver, she will oversee the region’s growth, including market developm
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial26.2.2024 16:00:00 EET | Press release
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), today announced the treatment of the first patient in the CONVERT II Pivotal Trial, a multicenter, international study evaluating the safety and effectiveness of the AeriSeal® System in limiting collateral ventilation in severe COPD/emphysema patients. Collateral ventilation is caused by openings in the lung fissures, or walls between the lung lobes. The AeriSeal System is designed to occlude these naturally occurring openings in a lobe targeted for bronchoscopic lung volume reduction (BLVR) and block collateral ventilation. Successful treatment with the AeriSeal System is followed by treatment with commercially available Zephyr® Valves. Pulmonx received a staged IDE approval by the Food and Drug Administration (FDA) to commence the CONVERT II Pivotal Trial for the AeriSeal System in late 2023. The goal of the CONVERT II Piv
Capcom Announces Million-Dollar Grand Prize for Capcom Pro Tour 2024!26.2.2024 14:36:00 EET | Press release
Capcom Co., Ltd. (TOKYO:9697) today announced that it will offer $1 million USD (approx. 150 million yen*1) as the grand prize for Capcom Pro Tour 2024, its series of esports tournaments held worldwide that feature the company’s storied Street Fighter series. Capcom has held the Capcom Pro Tour along with the world-championship tournament Capcom Cup each year since 2014, staging live competitions in more than 40 countries while carrying out online events in as many as 129 countries worldwide. Additionally, Capcom runs the competitive team-based Street Fighter League in Japan, the U.S.A., and Europe. To commemorate the release of Street Fighter 6, the latest title in the series, Capcom provided its largest-ever prize pool of over $2 million USD (approx. 300 million yen*1) in total prize money for the Capcom Pro Tour 2023. Capping off the season, the Capcom Cup X championship tournament was held from February 17-26 and finished in a flurry of excitement that saw UMA crowned victor after
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom